Home › Funds › DME Capital Management, LP › VTRS
DME Capital Management, LP position in VTRS
Viatris Inc · Health Care
DME Capital Management, LP reported holding 2,773,470 shares of VTRS (Viatris Inc) in its Q2 2026 13F filing — a position valued at US$44.0M, representing 1.13% of its reported portfolio and ranking #33 among its reported holdings. DME Capital Management, LP has disclosed VTRS holdings in 7 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DME Capital Management, LP's VTRS position evolved
DME Capital Management, LP first disclosed a stake in VTRS in Q1 2024 at 4,517,620 shares (US$53.9M). The position peaked in Q3 2024 at 7,270,430 shares, worth US$84.4M. Across 7 filings, DME Capital Management, LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,773,470 shares valued at US$44.0M — an increase of 955,900 shares quarter over quarter.. Notable position changes include a 64% increase in Q2 2024 (shares rose 9% over the following quarter), a 53% increase in Q2 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 4.52M | $53.94M | New |
| Q2 2024 | 7.40M | $78.66M | Add |
| Q3 2024 | 7.27M | $84.41M | Reduce |
| Q4 2024 | 5.79M | $72.02M | Reduce |
| Q1 2025 | 6.00M | $52.27M | Add |
| Q1 2026 | 1.82M | $24.56M | New |
| Q2 2026 | 2.77M | $44.04M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VTRS and 13F data
VTRS (Viatris Inc) is a Health Care company. 34 other funds we track also report a position in VTRS — the largest reported positions include DAVIS SELECTED ADVISERS (US$1.19B), Rubric Capital Management LP (US$542.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$320.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VTRS
- DAVIS SELECTED ADVISERS 75.23M sh · $1.19B · Q2 2026
- Rubric Capital Management LP 34.17M sh · $542.60M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 20.21M sh · $320.87M · Q2 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 9.88M sh · $156.85M · Q2 2026
- Callodine Capital Management, LP 8.00M sh · $127.05M · Q2 2026
More on DME Capital Management, LP
FAQ
How long has DME Capital Management, LP held VTRS?
DME Capital Management, LP has disclosed VTRS holdings in 7 of the last 10 reported quarters, going back to Q1 2024.
What is DME Capital Management, LP's current position in VTRS?
As of Q2 2026, DME Capital Management, LP holds 2.77M shares of VTRS (Viatris Inc), valued at $44.04M, representing 1.13% of its reported portfolio and ranking #33.
Has DME Capital Management, LP been buying or selling VTRS?
In the latest 13F filing (Q2 2026), DME Capital Management, LP increased its position in VTRS. The position peaked in Q3 2024 at 7.27M shares.
Which other funds hold VTRS?
Other major institutional holders of VTRS include DAVIS SELECTED ADVISERS, Rubric Capital Management LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.